Marshall Wace
CRXTW

Marshall Wace’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Marshall Wace’s Portfolio CRXTW Stock Details CRXTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-63,063
Closed -$24K – 4021
2022
Q2 		$24K Sell
63,063
-186,937
-75% -$18.4K ﹤0.01% 3356
2022
Q1 		$373K Hold
250,000
– – ﹤0.01% 2905
2021
Q4 		$608K Buy
250,000
+153,400
+159% +$78.4K ﹤0.01% 2703
2021
Q3 		$515K Buy
+96,600
New +$72.8K ﹤0.01% 2372

Other funds holding CRXTW

MSU
Mizuho Securities USA New York $4.24B AUM 22.54% 1-Year Est. Return